The National Institutes of Health held a workshop, addressing the risks associated with the newer diabetic drugs. These medications, known as Incretic Mimetics are coming under fire for alleged increased risk of pancreatic cancer. Merck & Co., Novo Nordisk A/S and others, the manufacturers of these drugs may be asked…
Updated: